Financhill
Sell
26

CARA Quote, Financials, Valuation and Earnings

Last price:
$5.07
Seasonality move :
-8.29%
Day range:
$5.00 - $5.13
52-week range:
$2.71 - $11.52
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.28x
P/B ratio:
33.04x
Volume:
2.6K
Avg. volume:
15.5K
1-year change:
-45.65%
Market cap:
$23.5M
Revenue:
$7.1M
EPS (TTM):
-$15.65

Earnings Data

Next earnings date for CARA
Mar 18
2025
Most recent earnings per share
-$1.73
Missed by $1.73
(Mar 18/2025)
Consensus Estimate
--
(Mar 18/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CARA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/18/2025 Q4 -- $1.5M -$1.73 -- --
11/14/2024 Q3 $1.6M $2.6M -$2.76 -$2.94 $0.18
08/14/2024 Q2 $1.2M $991K -$4.44 -$3.12 -$1.32
05/13/2024 Q1 $1.7M $2.1M -$6.72 -$4.84 -$1.88
03/04/2024 Q4 $9.1M $3M -$7.08 -$4.53 -$2.55
11/13/2023 Q3 $11.1M $4.9M -$6.24 -$5.83 -$0.41
08/07/2023 Q2 $6.7M $6.9M -$6.96 -$6.52 -$0.44
05/15/2023 Q1 $5M $6.2M -$5.88 -$6.37 $0.49
03/06/2023 Q4 $14.5M $3.3M -$6.72 -$4.24 -$2.48
11/07/2022 Q3 $8.9M $10.8M -$5.16 -$5.36 $0.20
08/08/2022 Q2 -- $23M -$0.96 -- --
05/09/2022 Q1 -- $4.8M -$6.24 -- --
03/01/2022 Q4 -- $821K -$7.56 -- --
11/08/2021 Q3 -- $20.3M -$0.24 -- --
08/09/2021 Q2 -- -- -$7.32 -- --
05/10/2021 Q1 -- $1.9M -$5.64 -- --
02/25/2021 Q4 -- $112.1M $20.28 -- --
11/09/2020 Q3 -- $9.3M -$4.20 -- --
08/10/2020 Q2 -- $5.6M -$6.48 -- --
05/11/2020 Q1 -- $8.1M -$7.44 -- --
02/27/2020 Q4 -- $4.5M -$7.32 -- --
11/05/2019 Q3 -- $5.8M -$8.88 -- --
08/07/2019 Q2 -- $5.2M -$6.96 -- --
05/07/2019 Q1 -- $4.4M -$6.72 -- --
03/12/2019 Q4 -- $5.5M -$6.24 -- --
11/06/2018 Q3 -- $5.1M -$6.12 -- --
08/07/2018 Q2 -- $2.9M -$6.24 -- --
05/09/2018 Q1 -- -- -$6.12 -- --
03/15/2018 Q4 -- -- -$5.16 -- --
11/02/2017 Q3 -- -- -$4.56 -- --
08/03/2017 Q2 -- -- -$3.48 -- --
05/04/2017 Q1 -- $911K -$9.72 -- --
03/09/2017 Q4 -- -- -$9.72 -- --
11/03/2016 Q3 -- -- -$5.04 -- --
08/04/2016 Q2 -- $79K -$5.76 -- --
05/05/2016 Q1 -- $7K -$4.68 -- --
03/10/2016 Q4 -- -- -$4.20 -- --
11/09/2015 Q3 -- $2.4M -$2.28 -- --
08/10/2015 Q2 -- $874K -$3.00 -- --
05/12/2015 Q1 -- $489K -$2.52 -- --

Cara Therapeutics Earnings Questions

  • How Much did Cara Therapeutics Generate in Revenue Last Quarter?

    Cara Therapeutics reported $1.5M worth of top line sales in its most recent quarter.

  • Did Cara Therapeutics Beat Earnings Last Quarter?

    Cara Therapeutics announced earnings per share of -$1.73 which represents a miss of analyst forecast a -- per share.

  • Is Cara Therapeutics Profitable?

    Cara Therapeutics reported $1.5M that represents $0.32 per share over the last quarter.

  • What is the Analyst Consensus for Cara Therapeutics EPS Next Year?

    Cara Therapeutics's earnings are forecast to decrease from -$15.53 per share to -$0.30 per share next year representing a decrease of -48.82%.

  • When is Cara Therapeutics's Earnings Date?

    Cara Therapeutics's next earnings date is March 18, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Reddit a Buy on the Dip?
Is Reddit a Buy on the Dip?

Reddit (NYSE:RDDT) share price has been on the proverbial ropes…

Qualcomm Stock: 5G Leader at a Bargain Price?
Qualcomm Stock: 5G Leader at a Bargain Price?

Chip giant QUALCOMM Incorporated (NASDAQ:QCOM) was the ultimate chip company…

What Is Buffett Buying and Selling Now?
What Is Buffett Buying and Selling Now?

In Q4 of last year, Warren Buffett made a few…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
59
GRRR alert for Mar 15

Gorilla Technology Group [GRRR] is up 29.72% over the past day.

Sell
49
SMTC alert for Mar 15

Semtech [SMTC] is up 21.28% over the past day.

Buy
62
PLPC alert for Mar 15

Preformed Line Products [PLPC] is up 17.38% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock